within Pharmacolibrary.Drugs.ATC.G;

model G03GA01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 2.666666666666667e-06,
    adminDuration  = 600,
    adminMass      = 5000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0058,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.009699999999999999,
    k12             = 0.37,
    k21             = 0.37
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03GA01</td></tr><td>route:</td><td>intramuscular</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Chorionic gonadotrophin (hCG) is a glycoprotein hormone produced during pregnancy by the placenta. It is primarily used as a fertility medication in men and women, for the treatment of infertility, hypogonadism, and cryptorchidism. It is also approved for use today and is listed under the ATC code G03GA01.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy male volunteers following a single intramuscular dose.</p><h4>References</h4><ol><li><p>Penzias, AS (2002). Luteal phase support. <i>Fertility and sterility</i> 77(2) 318–323. DOI:<a href=&quot;https://doi.org/10.1016/s0015-0282(01)02961-2&quot;>10.1016/s0015-0282(01)02961-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11821090/&quot;>https://pubmed.ncbi.nlm.nih.gov/11821090</a></p></li><li><p>Saal, W, et al., &amp; Happ, J (1991). Pharmacodynamics and pharmacokinetics after subcutaneous and intramuscular injection of human chorionic gonadotropin. <i>Fertility and sterility</i> 56(2) 225–229. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1712735/&quot;>https://pubmed.ncbi.nlm.nih.gov/1712735</a></p></li><li><p>Trinchard-Lugan, I, et al., &amp; Munafo, A (2002). Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers. <i>Reproductive biomedicine online</i> 4(2) 106–115. DOI:<a href=&quot;https://doi.org/10.1016/s1472-6483(10)61927-x&quot;>10.1016/s1472-6483(10)61927-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12470572/&quot;>https://pubmed.ncbi.nlm.nih.gov/12470572</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03GA01;
